Companies/Christina Lake Cannabis Corp.

Company profile

Christina Lake Cannabis Corp.

OTC: CLCFF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#618 of 1,394 Healthcare companies by revenue53rd-percentile growth

EA Score

64C

FH 74DQ —GM 52SS 32

v0.1 · 45/100 weight · provisional

↑ operating margin, return on assets · ↓ listing tenure, workforce scale

Methodology →

Revenue TTM

$9.6M

Rev growth YoY (TTM)

-11.8%

Net income (FY)

$783.5k

Employees

Market cap

$4.7M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$10.8M15.1M CAD2025

Net income$783.5k1.1M CAD2025

Operating income$1.6M2.2M CAD2025

Total assets$20.0M28.0M CAD2025

Liabilities$8.0M11.2M CAD2025

Equity$12.0M16.8M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

$7.1M

FY20

$2.9M

FY21

$7.8M

FY22

$8.7M

FY23

$10.0M

FY24

$10.8M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Christina Lake Cannabis Corp. booked $10.8M in FY2025 revenue, growing 7.7% year over year — about the middle of the pack among Healthcare companies we track, at a 7.3% net margin.

Peers · Healthcare

Xcelerate Inc.——Avant Brands Inc.59C Mangoceuticals, Inc.29D Quince Therapeutics, Inc.——

Key facts

CEOMark Aiken

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: CLCFF

Employees15

IPO date2021-01-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.